|
Market Closed -
CBOE
18:00:00 09/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 8,641.79 HUF | 0.00% |
|
0.00% | +1.07% |
| 09-18 | EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug | MT |
| 08-11 | Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026 |
Company Valuation: Gedeon Richter PLC
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,619,625 | 1,542,290 | 1,627,029 | 1,893,161 | 1,799,226 | 2,252,523 | - | - |
| Change | - | -4.77% | 5.49% | 16.36% | -4.96% | 25.19% | - | - |
| Enterprise Value (EV) 1 | 1,559,769 | 1,395,557 | 1,546,536 | 1,782,343 | 1,588,618 | 1,990,047 | 1,842,512 | 1,715,544 |
| Change | - | -10.53% | 10.82% | 15.25% | -10.87% | 25.27% | -7.41% | -6.89% |
| P/E | 11.6x | 9.94x | 10.2x | 7.96x | 7.76x | 9.09x | 7.77x | 7.19x |
| PBR | 1.78x | 1.47x | 1.44x | 1.49x | 1.31x | 1.5x | 1.36x | 1.23x |
| PEG | - | 0.9x | 3.41x | 0.2x | -2.82x | 1.31x | 0.5x | 0.89x |
| Capitalization / Revenue | 2.57x | 1.92x | 2.02x | 2.21x | 1.94x | 2.37x | 2.21x | 2.06x |
| EV / Revenue | 2.47x | 1.74x | 1.92x | 2.08x | 1.71x | 2.09x | 1.8x | 1.57x |
| EV / EBITDA | 8.86x | 7.1x | 6.43x | 5.74x | 4.5x | 5.41x | 4.65x | 4.04x |
| EV / EBIT | 11.5x | 9.09x | 8.15x | 6.82x | 5.42x | 6.58x | 5.53x | 4.78x |
| EV / FCF | -460x | 12.3x | 17.9x | 8.26x | 7.56x | 8.81x | 8.03x | 6.93x |
| FCF Yield | -0.22% | 8.12% | 5.6% | 12.1% | 13.2% | 11.4% | 12.4% | 14.4% |
| Dividend per Share 2 | 225 | 390 | - | - | - | 603.6 | 677 | 738.7 |
| Rate of return | 2.58% | 4.7% | - | - | - | 4.89% | 5.48% | 5.98% |
| EPS 2 | 751 | 835 | 860 | 1,307 | 1,271 | 1,359 | 1,589 | 1,718 |
| Distribution rate | 30% | 46.7% | - | - | - | 44.4% | 42.6% | 43% |
| Net sales 1 | 630,595 | 802,755 | 805,158 | 857,545 | 928,962 | 951,368 | 1,020,834 | 1,093,689 |
| EBITDA 1 | 176,123 | 196,480 | 240,625 | 310,678 | 353,314 | 367,576 | 396,366 | 425,015 |
| EBIT 1 | 135,832 | 153,555 | 189,817 | 261,157 | 292,851 | 302,220 | 332,887 | 359,032 |
| Net income 1 | 139,626 | 155,581 | 158,850 | 239,244 | 232,335 | 254,304 | 290,549 | 314,929 |
| Net Debt 1 | -59,856 | -146,733 | -80,493 | -110,818 | -210,608 | -262,476 | -410,012 | -536,980 |
| Reference price 2 | 8,725.00 | 8,300.00 | 8,750.00 | 10,400.00 | 9,865.00 | 12,350.00 | 12,350.00 | 12,350.00 |
| Nbr of stocks (in thousands) | 185,630 | 185,818 | 185,946 | 182,035 | 182,385 | 182,391 | - | - |
| Announcement Date | 3/2/22 A | 2/28/23 A | 2/29/24 A | 4/7/25 A | 2/27/26 A | - | - | - |
1HUF in Million2HUF
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.21x | 12.07x | 24.51x | 0.59% | 1,043B | |
| 28.53x | 6.31x | 18.08x | 2.08% | 618B | |
| 34.51x | 8.02x | 16.59x | 2.55% | 481B | |
| 103.58x | 5.8x | 24.76x | 2.4% | 351B | |
| 19.03x | 4.65x | 11.56x | 2.84% | 338B | |
| 19.78x | 5.2x | 12.8x | 3.06% | 269B | |
| 20.32x | 4.17x | 11.93x | 2.13% | 244B | |
| 25.73x | 6.72x | 11.97x | 2.48% | 220B | |
| -44.49x | 6.55x | 25.51x | 2.24% | 182B | |
| Average | 26.69x | 6.61x | 17.52x | 2.26% | 416.3B | |
| Weighted average by Cap. | 31.90x | 7.75x | 18.94x | 1.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RICHTER Stock
- 0QFP Stock
- Valuation Gedeon Richter PLC
Select your edition
All financial news and data tailored to specific country editions
